Osstem Implant Acquires Implacil de Bortoli 

Osstem Implant Acquires Implacil de Bortoli 

Osstem Implant announced on May 2 that it entered into an agreement to acquire a 100% stake in Implacil de Bortoli for $89.8 million.  Implacil de Bortoli is a Brazilian dental implant firm. With a portfolio of approximately 1,300 product items, the company offers a complete dental solution, ranging from dental implants and prosthetic components to surgical kits and biomaterials. The company has an annual production capacity of 9.1 million units and operates five distribution centers covering more than 13,000 clients across Brazil. According to the press release, the company reported $874 million in revenue in 2023.  Osstem Implant, which is backed by MBK Partners and UCK... Read More »
The Pennant Group Acquires South Davis Home Health and South Davis Hospice

The Pennant Group Acquires South Davis Home Health and South Davis Hospice

The Pennant Group, Inc. announced that it has acquired South Davis Home Health and South Davis Hospice, which provides skilled home health and hospice services in Davis County, Utah. The home health and hospice provider is based in Bountiful, Utah. The Pennant Group is a holding company of independent operating subsidiaries that provide healthcare services through 112 home health and hospice agencies and 53 senior living communities located in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. Each of these businesses is operated by a separate, independent operating subsidiary that has its own management, employees... Read More »
PE Firm Knox Lane Partners with All Star Healthcare Solutions

PE Firm Knox Lane Partners with All Star Healthcare Solutions

Knox Lane announced on May 2 that it has acquired a majority stake in All Star Healthcare Solutions. According to data captured in the LevinPro HC database, this acquisition represents the fourth healthcare staffing transaction of 2024. There were 29 healthcare staffing deals announced during 2023, and 35 announced during 2022. All Star Healthcare Solutions All Star is a provider of specialty-focused locum tenens and permanent placement opportunities for physicians and advanced practitioners in the United States. Headquartered in Deerfield Beach, Florida, All Star provides its services across all 50 states to more than 150 unique hospital systems and more than 400 individual healthcare... Read More »
NuvoAir Medical Partners Acquires Privia Medical Group – Georgia 

NuvoAir Medical Partners Acquires Privia Medical Group – Georgia 

On May 1, NuvoAir Medical Partners announced that it was entering into an agreement to acquire Privia Medical Group – Georgia.   Privia Medical Group – Georgia is part of Privia Health. It is a technology-driven, national physician enablement accountable care organization (ACO) that collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual settings. Privia Medical Group – Georgia has more than 380 providers that care for more than 515,000 patients.  NuvoAir Medical is at the forefront of value-based specialty care,... Read More »
Capitol Pain Institute Purchases Pain Care Surgery of Louisville

Capitol Pain Institute Purchases Pain Care Surgery of Louisville

Capitol Pain Institute (CPI) has acquired Pain Care Surgery of Louisville, an ambulatory surgical center (ASC) in Louisville, Kentucky. This acquisition will allow CPI to offer more advanced procedures, including spinal cord and peripheral nerve stimulation, interspinous stabilization and fixation and posterior SI joint fusion. CPI utilizes a range of interventional treatments and medication optimization. It is owned by Iron Path Capital, a Nashville, Tennessee-based private equity firm focused on building differentiated businesses in the healthcare and specialty industrials sectors. Capitol Pain currently operates in six states: Colorado, Indiana, Kentucky, Minnesota, Ohio and Texas. With... Read More »
PE-Backed Your Behavioral Health Acquires Insight Treatment Programs

PE-Backed Your Behavioral Health Acquires Insight Treatment Programs

Your Behavioral Health, a portfolio company of private investment firm Comvest Partners, has acquired Insight Treatment Programs. Insight joins Your Behavioral Health’s regional network of behavioral health clinics providing mental health and addiction treatment care for teens and adults. Founded in 1993, Insight Treatment Programs is a Southern California provider of teen outpatient mental health and addiction treatment programs. Insight operates six locations across the Los Angeles and Modesto, California MSAs, providing intensive outpatient services and community-focused support to adolescents and their families. Your Behavioral Health is a Torrance, California-based behavioral health... Read More »
Opya Announces Acquisition to Expand Autism Therapy Services

Opya Announces Acquisition to Expand Autism Therapy Services

Opya ended April 2024 with a deal announcement. The San Mateo, California-based company announced the acquisition of the Center for Autism Spectrum Therapy (CAST), an early intervention autism therapy clinic provider located in Culver City, California. Founded in 2016, Opya provides early intervention therapy for newly diagnosed children aged 18 months up to 6 years old, in addition to providing accompanying speech and occupational therapies via telehealth. The CAST acquisition expands Opya’s Southern California presence and adds a clinic-based option to Opya’s personalized in-home autism services. Financial terms of the deal were not disclosed. According to data captured in the LevinPro... Read More »

Fragmented ASC Market Poised for M&A Growth

As the healthcare market moves toward a value-based care model, outpatient settings and services will only rise in demand from investors and patients alike. Ambulatory surgery centers, or ASCs, will be one of the most valuable assets in this shift in the healthcare industry. With several tailwinds driving the ASC investment market, including demographic and reimbursement benefits, a fragmented industry and the versatility of ASC services and specialties, investors should pay close attention to this market. Market Overview & Players According to the Ambulatory Surgery Center Association (ASCA), ASCs are healthcare facilities focused on providing same-day surgical care, including... Read More »
Ivy Fertility Adds Dallas IVF to Network

Ivy Fertility Adds Dallas IVF to Network

Ivy Fertility, a global leader in advanced reproductive technology, in-vitro fertilization (IVF) and third-party reproduction, announced on April 29 that it has acquired Dallas IVF. The addition of Dallas IVF expands Ivy Fertility’s presence in Texas. Dallas IVF is a fertility practice serving patients in the greater Dallas-Fort Worth MSA. With locations in Dallas, Frisco, Tyler and McKinney, Texas, Dallas IVF has helped more than 13,000 babies come into the world since its founding in 1997. The Frisco location is also home to a state-of-the-art IVF lab and surgery center. According to its website, the practice has four providers on staff. Ivy Fertility, a portfolio company of... Read More »
Deciphera Pharmaceuticals to be Acquired by Ono Pharmaceutical for $2.4 Billion

Deciphera Pharmaceuticals to be Acquired by Ono Pharmaceutical for $2.4 Billion

Deciphera Pharmaceuticals announced on April 29 that it has entered into a definitive merger agreement with Ono Pharmaceutical Co., Ltd. Ono will acquire all outstanding shares of Deciphera common stock for $25.60 per share in cash through a tender offer followed by a merger of Deciphera with a wholly-owned subsidiary of Ono, for a total equity value of $2.4 billion. Deciphera Pharmaceuticals is a biopharmaceutical company focused on discovering, developing and commercializing important new medicines to improve the lives of people with cancer. In addition to advancing multiple product candidates from our platform in clinical studies, QINLOCK® is Deciphera’s switch-control inhibitor for the... Read More »